| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S13402-015-0240-X |
| P698 | PubMed publication ID | 26335100 |
| P2093 | author name string | Mahboob Ul Hussain | |
| Nisar Ahmad Chowdri | |||
| Raihana Maqbool | |||
| Rehana Ismail | |||
| Rabiya Rashid | |||
| Saif Niaz | |||
| P2860 | cites work | Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy. | Q54394304 |
| p53 — Master and Commander | Q59238393 | ||
| miRNAs in head and neck cancer revisited | Q63459877 | ||
| The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth | Q73085587 | ||
| MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma | Q87351725 | ||
| Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status | Q87401555 | ||
| Connexins: a myriad of functions extending beyond assembly of gap junction channels | Q21245510 | ||
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| The complexity of p53 modulation: emerging patterns from divergent signals | Q28284854 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Circulating MiR-125b as a marker predicting chemoresistance in breast cancer | Q28482362 | ||
| DNA damage activates p53 through a phosphorylation-acetylation cascade | Q29616294 | ||
| Physiological and physiopathological aspects of connexins and communicating gap junctions in spermatogenesis | Q33856936 | ||
| Activation of p53 by oncogenes | Q33872973 | ||
| Internal ribosomal entry site (IRES) activity generates endogenous carboxyl-terminal domains of Cx43 and is responsive to hypoxic conditions | Q33947209 | ||
| Gap junctions: basic structure and function. | Q34007559 | ||
| Structural and functional diversity of connexin genes in the mouse and human genome | Q34137753 | ||
| Gap junctions as targets for cancer chemoprevention and chemotherapy | Q35007606 | ||
| miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9. | Q35009302 | ||
| MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways | Q35028282 | ||
| Regulation of connexin expression | Q36344530 | ||
| The role of connexins in controlling cell growth and gene expression | Q36803102 | ||
| Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion | Q37142419 | ||
| P53 protein in proliferation, repair and apoptosis of cells | Q37720224 | ||
| Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis | Q37903701 | ||
| Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action | Q38012626 | ||
| p53 mutations in cancer | Q38069463 | ||
| MicroRNAs and human diseases: diagnostic and therapeutic potential | Q38184973 | ||
| Good guy or bad guy: the opposing roles of microRNA 125b in cancer | Q38207752 | ||
| miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype | Q39162646 | ||
| Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome | Q39484788 | ||
| Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy. | Q40476195 | ||
| Involvement of p53 in cell differentiation and development | Q41592444 | ||
| Dual functions for connexins: Cx43 regulates growth independently of gap junction formation | Q42823532 | ||
| Gene expression alterations in connexin null mice extend beyond the gap junction. | Q47599681 | ||
| A novel saliva-based microRNA biomarker panel to detect head and neck cancers. | Q53025206 | ||
| The chemosensitivity of testicular germ cell tumors. | Q53059668 | ||
| The cancer genome: from structure to function. | Q53087702 | ||
| Pathological implications of Cx43 down-regulation in human colon cancer. | Q53237826 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 443-451 | |
| P577 | publication date | 2015-09-03 | |
| P1433 | published in | Cellular Oncology | Q2160503 |
| P1476 | title | The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers | |
| P478 | volume | 38 |
| Q55011586 | Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer. |
| Q52716310 | Connexins: Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease. |
| Q37613777 | Gap junctions and cancer: communicating for 50 years |
| Q31157753 | SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data |
| Q52563269 | The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis. |
| Q90369241 | Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43 |
| Q52932292 | microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. |
Search more.